Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Pariente

Showing results (191-200 of 220) with videos related to

Pageof 22
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2016
Atropinic (Anticholinergic) Burden in Parkinson's DiseaseSibylle De Germay, Jean-Louis Montastruc, Vanessa Rousseau, et al.
Drug Safety|January 6, 2026
Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction CheckersLelio Crupi, Louis Letinier, Vianney Jouhet, et al.
BMC Cancer|December 29, 2017
Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control studySabrina Falkowski, Jean-Baptiste Woillard, Deborah Postil, et al.
Drug Safety|October 9, 2015
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO ProjectEmanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, et al.
Heart (British Cardiac Society)|May 4, 2018
Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitorsVirginie Grouthier, Benedicte Lebrun-Vignes, Andrew M Glazer, et al.
Archives of Cardiovascular Diseases|November 6, 2019
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance studyMarie Bretagne, Bénédicte Lebrun-Vignes, Antoine Pariente, et al.
Drug Safety|January 15, 2013
A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databasesPreciosa M Coloma, Paul Avillach, Francesco Salvo, et al.
Therapie|June 1, 2021
French organization for the pharmacovigilance of COVID-19 vaccines: A major challengeClémence Lacroix, Francesco Salvo, Valérie Gras-Champel, et al.
Therapie|December 26, 2022
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Therapie|December 28, 2022
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Pageof 22

Showing results (191-200 of 220) with videos related to

Sort By:
Pageof 22
Movement Disorders : Official Journal of the Movement Disorder Society|March 31, 2016
Atropinic (Anticholinergic) Burden in Parkinson's DiseaseSibylle De Germay, Jean-Louis Montastruc, Vanessa Rousseau, et al.
Drug Safety|January 6, 2026
Standardizing and Comparing Management Recommendations for Potential Drug-Drug Interactions Across Different Interaction CheckersLelio Crupi, Louis Letinier, Vianney Jouhet, et al.
BMC Cancer|December 29, 2017
Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control studySabrina Falkowski, Jean-Baptiste Woillard, Deborah Postil, et al.
Drug Safety|October 9, 2015
The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO ProjectEmanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, et al.
Heart (British Cardiac Society)|May 4, 2018
Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitorsVirginie Grouthier, Benedicte Lebrun-Vignes, Andrew M Glazer, et al.
Archives of Cardiovascular Diseases|November 6, 2019
Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance studyMarie Bretagne, Bénédicte Lebrun-Vignes, Antoine Pariente, et al.
Drug Safety|January 15, 2013
A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databasesPreciosa M Coloma, Paul Avillach, Francesco Salvo, et al.
Therapie|June 1, 2021
French organization for the pharmacovigilance of COVID-19 vaccines: A major challengeClémence Lacroix, Francesco Salvo, Valérie Gras-Champel, et al.
Therapie|December 26, 2022
What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Therapie|December 28, 2022
Antoine Pariente, Joëlle Micallef, Amir Lahouegue, et al.
Pageof 22